Cargando…

Indomethacin for refractory COVID or post-COVID headache: a retrospective study

BACKGROUND: COVID-19, a disease caused by SARS-CoV-2, manifests with headache, both in the acute phase and as a post-infection symptom, which may be refractory to usual analgesics. OBJECTIVES: Investigate the therapeutic response of refractory COVID or post-COVID headache to indomethacin. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krymchantowski, Abouch V., Silva-Néto, Raimundo Pereira, Jevoux, Carla, Krymchantowski, Ana Gabriela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453033/ https://www.ncbi.nlm.nih.gov/pubmed/34546559 http://dx.doi.org/10.1007/s13760-021-01790-3

Ejemplares similares

Monoclonal antibodies for chronic migraine and medication overuse headache: A real-world study
por: Krymchantowski, Abouch V., et al.
Publicado: (2023)

Medication-overuse headache—a review of different treatment strategies
por: Krymchantowski, Abouch, et al.
Publicado: (2023)

Psychosis and Bilateral Peripheral Facial Palsy Associated With COVID-19
por: Jevoux, Carla, et al.
Publicado: (2022)

Correction: Krymchantowski, A.V.; et al. Medication-Overuse Headache: Differences between Daily and Near-Daily Headache Patients; Brain Sciences 2016, 6, 30
por: Krymchantowski, Abouch V., et al.
Publicado: (2017)

Medication-Overuse Headache: Differences between Daily and Near-Daily Headache Patients
por: Krymchantowski, Abouch V., et al.
Publicado: (2016)

Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders
por: Krymchantowski, Abouch Valenty, et al.
Publicado: (2011)

Acute treatment of migraine. Breaking the paradigm of monotherapy
por: Krymchantowski, Abouch Valenty
Publicado: (2004)

The use of combination therapies in the acute management of migraine
por: Krymchantowski, Abouch Valenty
Publicado: (2006)

Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine
por: Krymchantowski, Abouch Valenty, et al.
Publicado: (2004)

O004. Refractory chronic cluster headache responding absolutely to indomethacin
por: Lisotto, Carlo, et al.
Publicado: (2015)

The spectrum of indomethacin-responsive headaches in children and adolescents
por: Myers, Kenneth A, et al.
Publicado: (2022)

TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points
por: Bigal, Marcelo E., et al.
Publicado: (2016)

Differential actions of indomethacin: clinical relevance in headache
por: Summ, Oliver, et al.
Publicado: (2021)

A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headaches
por: Summ, Oliver, et al.
Publicado: (2010)

Are Cox-2 drugs the second line option in indomethacin responsive headaches?
por: Porta-Etessam, Jesús, et al.
Publicado: (2010)

Headache during COVID-19 and post COVID-19 headache
por: Anwar Garcia Santos, Raul, et al.
Publicado: (2021)

Relapsing remitting hypnic headache responsive to indomethacin in an adolescent: a case report
por: Prakash, Sanjay, et al.
Publicado: (2008)

Sphenopalatine ganglion block for refractory COVID-19 headache: a descriptive case series
por: Machado, Felipe Chiodini, et al.
Publicado: (2021)

Characterization of Headache in COVID-19: a Retrospective Multicenter Study
por: dos Anjos de Paula, Rafael César, et al.
Publicado: (2021)

Migraine patients’ journey until a tertiary headache center: an observational study
por: Peres, Mario Fernando Prieto, et al.
Publicado: (2019)

Hybrid Nanobeads for Oral Indomethacin Delivery
por: Bonetti, Flávia Monique Rocha, et al.
Publicado: (2022)

Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors
por: Gonzalez-Martinez, Alicia, et al.
Publicado: (2022)

Post-COVID Headache: A Literature Review
por: Chhabra, Nikita, et al.
Publicado: (2022)

Indomethacin: Can It Counteract Bradykinin Effects in COVID-19 Patients?
por: Alkotaji, Myasar, et al.
Publicado: (2021)

Pregabalin for refractory postdural puncture headache
por: Yadav, Anamika, et al.
Publicado: (2015)

Treatment-Refractory Headache in the Setting of COVID-19 Pneumonia: Migraine or Meningoencephalitis? Case Report
por: Arca, Karissa N., et al.
Publicado: (2020)

Long-COVID Headache
por: Martelletti, Paolo, et al.
Publicado: (2021)

Formulation and evaluation of indomethacin biomicroparticles
por: Gupta, Sudeep, et al.
Publicado: (2012)

Indomethacin-Induced Hypertensive Crisis
por: Dhungana, Bibek, et al.
Publicado: (2021)

Formulation Development and Release Studies of Indomethacin Suppositories
por: Sah, M. L., et al.
Publicado: (2008)

Lifestyle modifications as therapy for medication refractory post-traumatic headache (PTHA) in the military population of Okinawa
por: Baker, Virginia B., et al.
Publicado: (2018)

Refractory migraine in a headache clinic population
por: Irimia, Pablo, et al.
Publicado: (2011)

Post-infectious headache: a reactive headache?
por: Prakash, Sanjay, et al.
Publicado: (2011)

Frequency and phenotype of headache in covid-19: a study of 2194 patients
por: García-Azorín, David, et al.
Publicado: (2021)

Comparison of indomethacin suppository and lidocaine cream on post-episiotomy pain: A randomized trial
por: Delaram, Masoumeh, et al.
Publicado: (2015)

Underutilization of prophylactic rectal indomethacin and pancreatic duct stent for prevention of post-ERCP Pancreatitis
por: Issak, Abdulfatah, et al.
Publicado: (2021)

Post COVID-19 vaccination headache: A clinical and epidemiological evaluation
por: Ceccardi, Giulia, et al.
Publicado: (2022)

Preparation and Comparative Bioavailability Studies of Indomethacin-Loaded Cetyl Alcohol Microspheres
por: Gupta, N. Vishal, et al.
Publicado: (2013)

Study of Physico-Chemical Properties and Morphology of Phospholipid Composition of Indomethacin
por: Tikhonova, Elena G., et al.
Publicado: (2022)

Preparation and in-vitro evaluation of indomethacin nanoparticles
por: Rezaei Mokarram, A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_mddspbt4qntlbiqii2b8sk408f